Skip to content
  • About Us
    • Careers
  • Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Contact

Industry Updates

  • Back to News & Insights

Medical Technology M&A Pulse – Q1 2022

  • May 11, 2022
  • Industry Updates
  • Medical Technology
2022 Q1: A Tumultuous Start to a Critical Year
  • 2022 started much as 2020 and 2021 had ended, with the world in the midst of a new COVID-19 outbreak, this one tied to the much milder Omicron variant. Fortunately, this variant’s emergence as the dominant strain of COVID improved the global health situation enough that countries worldwide began lifting restrictions and returning life to something resembling pre-pandemic normal.
  • On top of COVID, the first quarter was defined by the outbreak of armed conflict between Russia and Ukraine, which has had major impacts on the global supply chain for key natural resources such as gas and wheat. Equity markets reflected this negative sentiment, with the S&P 500 and Dow Jones both down during the quarter.
  • M&A transaction volume was down from the record pace of 2021’s first quarter, though still at a very healthy level, exceeding 2018 and 2020’s first quarter marks, and down slightly from 2019’’s. Valuation metrics remained advantageous for sellers, with both mean and median TEV / EBITDA multiples up from 2021-year end levels.
  • The 4 tracked medical subsector indices all outperformed the benchmark S&P 500 Growth Index, which was down 9.5%, and three of the medical indices outperformed the Dow Jones Industrial Average which was down 5.2%.

 

Read Medical Technology M&A Pulse Q1 2022 Full Report

Download Preview

Stay Informed

Subscribe to our newsletter for the latest industry updates

Subscribe

Recent Publications

Human Capital Management M&A Pulse – Q4 2022
Plastics M&A Update – November 2022
Packaging M&A Update – November 2022
Industrial Distributor M&A Pulse – Q3 2022
Food & Beverage M&A Pulse – Q3 2022
Contact

Follow Us On

Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

Services

  • Buy Side Advisory
  • Capital Raising
  • Sell Side Advisory
  • Transaction Planning & Readiness Review

Industry Expertise

  • Business Services & Technology
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives
  • Events

PMCF is a trade name for PMCF Advisors, LLC and P&M Corporate Finance, LLC. The term “PMCF” refers to one or more of these legally separate and independent advisory practices. P&M Corporate Finance, LLC provides capital raising and private placement services that require registration as a broker-dealer.

©2022 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​